Iberdomide Increases Innate and Adaptive Immune Cell Subsets in the Bone Marrow of Patients with Relapsed/refractory Multiple Myeloma
CELL REPORTS MEDICINE(2024)
Key words
iberdomide,CC-220,multiple myeloma,myeloma,plasma cell,bone marrow,immune microenvironment,tumor microenvironment,mass cytometry,CyTOF
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined